Purpose of the studyTo assess statistical agreement of metabolic syndrome (MS) ATPIII, IDF, EGIR and AACE classification in HIV-infected patients and association with body fat redistribution.MethodsCross-sectional observational study that included all consecutive HIV-infected patients seen at a metabolic clinic who were screened for MS and had a clinical and radiological lipodystrophy (LD) evaluation. Cohen's Kappa statistic was calculated to assess statistical agreement between different MS classifications. Logistic regression models were performed to identify factors associated with different MS classifications. (Tables 1 and 2.)Table 1. K of Cohen shows a low level of agreement between MS classifications.Summary of results1,348 pts were ...
INTRODUCTION: Combined antiretroviral therapy (cART) in the treatment of HIV-1 infection has been as...
INTRODUCTION: This study describes the characteristics of the metabolic syndrome in HIV-positive pat...
Methods This was a cross-sectional observational study that included all consecutive HIV-infected pa...
Purpose of the studyTo assess statistical agreement of metabolic syndrome (MS) ATPIII, IDF, EGIR and...
The aim of our study is to assess K statistic of Metabolic Syndrome (MS) Adult Treatment Panel III (...
The aim of our study is to analyse metabolic syndrome (MS) prevalence in a cohort of HIV patients an...
Abstract Background In HIV-infected patients, combination antiretroviral therapy (cART) is associate...
Background: Metabolic Syndrome (MetS) is based on the same individual components, but has received s...
SummaryObjectivePrevalence of chronic complications of HIV infection is increasing and early recogni...
The metabolic syndrome (MetS), a cluster of risk factors for cardiovascular disease and type 2 diabe...
This study describes the characteristics of the metabolic syndrome in HIV-positive patients in the D...
INTRODUCTION: This study describes the characteristics of the metabolic syndrome in HIV-positive pat...
Objective: To determine the association between phenotypes of HIV associated lipodystrophy and vario...
Objectives. We determined metabolic syndrome (MetS) prevalence and assessed the agreement between di...
INTRODUCTION: Combined antiretroviral therapy (cART) in the treatment of HIV-1 infection has been as...
INTRODUCTION: This study describes the characteristics of the metabolic syndrome in HIV-positive pat...
Methods This was a cross-sectional observational study that included all consecutive HIV-infected pa...
Purpose of the studyTo assess statistical agreement of metabolic syndrome (MS) ATPIII, IDF, EGIR and...
The aim of our study is to assess K statistic of Metabolic Syndrome (MS) Adult Treatment Panel III (...
The aim of our study is to analyse metabolic syndrome (MS) prevalence in a cohort of HIV patients an...
Abstract Background In HIV-infected patients, combination antiretroviral therapy (cART) is associate...
Background: Metabolic Syndrome (MetS) is based on the same individual components, but has received s...
SummaryObjectivePrevalence of chronic complications of HIV infection is increasing and early recogni...
The metabolic syndrome (MetS), a cluster of risk factors for cardiovascular disease and type 2 diabe...
This study describes the characteristics of the metabolic syndrome in HIV-positive patients in the D...
INTRODUCTION: This study describes the characteristics of the metabolic syndrome in HIV-positive pat...
Objective: To determine the association between phenotypes of HIV associated lipodystrophy and vario...
Objectives. We determined metabolic syndrome (MetS) prevalence and assessed the agreement between di...
INTRODUCTION: Combined antiretroviral therapy (cART) in the treatment of HIV-1 infection has been as...
INTRODUCTION: This study describes the characteristics of the metabolic syndrome in HIV-positive pat...
Methods This was a cross-sectional observational study that included all consecutive HIV-infected pa...